Patent · US Active

Process methods for phosphatidylinositol 3-kinase inhibitors

US10954199B2 · kind B2 · utility

0Cited by
78References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 2019
Grant dateMar 23, 2021
Priority date
Expiry dateAug 6, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound intermediates relating to these processes are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.